nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—Hypertension—Mitoxantrone—hematologic cancer	0.000469	0.000718	CcSEcCtD
Terlipressin—Hypertension—Irinotecan—hematologic cancer	0.000469	0.000718	CcSEcCtD
Terlipressin—Headache—Bexarotene—hematologic cancer	0.000468	0.000717	CcSEcCtD
Terlipressin—Headache—Dasatinib—hematologic cancer	0.000468	0.000717	CcSEcCtD
Terlipressin—Headache—Fludarabine—hematologic cancer	0.000467	0.000715	CcSEcCtD
Terlipressin—Nausea—Busulfan—hematologic cancer	0.000467	0.000714	CcSEcCtD
Terlipressin—Myocardial infarction—Betamethasone—hematologic cancer	0.000467	0.000714	CcSEcCtD
Terlipressin—Myocardial infarction—Dexamethasone—hematologic cancer	0.000467	0.000714	CcSEcCtD
Terlipressin—Tachycardia—Carmustine—hematologic cancer	0.000466	0.000713	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Vinorelbine—hematologic cancer	0.000464	0.000711	CcSEcCtD
Terlipressin—Nervous system disorder—Alitretinoin—hematologic cancer	0.000464	0.000709	CcSEcCtD
Terlipressin—Chest pain—Mitoxantrone—hematologic cancer	0.000463	0.000708	CcSEcCtD
Terlipressin—Diarrhoea—Cladribine—hematologic cancer	0.000462	0.000707	CcSEcCtD
Terlipressin—Tachycardia—Alitretinoin—hematologic cancer	0.000461	0.000706	CcSEcCtD
Terlipressin—Skin disorder—Alitretinoin—hematologic cancer	0.000459	0.000703	CcSEcCtD
Terlipressin—Nervous system disorder—Ifosfamide—hematologic cancer	0.000458	0.000701	CcSEcCtD
Terlipressin—Hypertension—Gemcitabine—hematologic cancer	0.000457	0.000699	CcSEcCtD
Terlipressin—Skin disorder—Ifosfamide—hematologic cancer	0.000454	0.000694	CcSEcCtD
Terlipressin—Nausea—Procarbazine—hematologic cancer	0.000453	0.000693	CcSEcCtD
Terlipressin—Chest pain—Gemcitabine—hematologic cancer	0.000451	0.00069	CcSEcCtD
Terlipressin—Hot flush—Epirubicin—hematologic cancer	0.00045	0.000688	CcSEcCtD
Terlipressin—Vomiting—Chlorambucil—hematologic cancer	0.000449	0.000687	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—hematologic cancer	0.000448	0.000685	CcSEcCtD
Terlipressin—Nervous system disorder—Vincristine—hematologic cancer	0.000447	0.000683	CcSEcCtD
Terlipressin—Menopausal symptoms—Epirubicin—hematologic cancer	0.000446	0.000682	CcSEcCtD
Terlipressin—Nausea—Bexarotene—hematologic cancer	0.000444	0.000679	CcSEcCtD
Terlipressin—Nausea—Dasatinib—hematologic cancer	0.000444	0.000679	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Thiotepa—hematologic cancer	0.000443	0.000679	CcSEcCtD
Terlipressin—Dyspnoea—Thalidomide—hematologic cancer	0.000443	0.000678	CcSEcCtD
Terlipressin—Nausea—Fludarabine—hematologic cancer	0.000443	0.000678	CcSEcCtD
Terlipressin—Diarrhoea—Vinblastine—hematologic cancer	0.000443	0.000678	CcSEcCtD
Terlipressin—Vomiting—Nilotinib—hematologic cancer	0.000439	0.000672	CcSEcCtD
Terlipressin—Vomiting—Imatinib—hematologic cancer	0.000437	0.000668	CcSEcCtD
Terlipressin—Abdominal pain—Bortezomib—hematologic cancer	0.000435	0.000666	CcSEcCtD
Terlipressin—Bradycardia—Betamethasone—hematologic cancer	0.000435	0.000666	CcSEcCtD
Terlipressin—Bradycardia—Dexamethasone—hematologic cancer	0.000435	0.000666	CcSEcCtD
Terlipressin—Nervous system disorder—Irinotecan—hematologic cancer	0.000435	0.000666	CcSEcCtD
Terlipressin—Tachycardia—Mitoxantrone—hematologic cancer	0.000433	0.000662	CcSEcCtD
Terlipressin—Headache—Nilotinib—hematologic cancer	0.000433	0.000662	CcSEcCtD
Terlipressin—Cardiac failure—Epirubicin—hematologic cancer	0.000431	0.00066	CcSEcCtD
Terlipressin—Skin disorder—Mitoxantrone—hematologic cancer	0.000431	0.000659	CcSEcCtD
Terlipressin—Headache—Imatinib—hematologic cancer	0.00043	0.000658	CcSEcCtD
Terlipressin—Vomiting—Cladribine—hematologic cancer	0.000429	0.000657	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Thalidomide—hematologic cancer	0.000429	0.000656	CcSEcCtD
Terlipressin—Dyspnoea—Carmustine—hematologic cancer	0.000425	0.000651	CcSEcCtD
Terlipressin—Abdominal pain—Vinorelbine—hematologic cancer	0.000425	0.000651	CcSEcCtD
Terlipressin—Nervous system disorder—Gemcitabine—hematologic cancer	0.000424	0.000648	CcSEcCtD
Terlipressin—Headache—Cladribine—hematologic cancer	0.000423	0.000647	CcSEcCtD
Terlipressin—Hyponatraemia—Epirubicin—hematologic cancer	0.000423	0.000646	CcSEcCtD
Terlipressin—Dyspnoea—Alitretinoin—hematologic cancer	0.000421	0.000645	CcSEcCtD
Terlipressin—Diarrhoea—Melphalan—hematologic cancer	0.000421	0.000645	CcSEcCtD
Terlipressin—Skin disorder—Gemcitabine—hematologic cancer	0.00042	0.000642	CcSEcCtD
Terlipressin—Nausea—Chlorambucil—hematologic cancer	0.00042	0.000642	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—hematologic cancer	0.000417	0.000638	CcSEcCtD
Terlipressin—Dyspnoea—Ifosfamide—hematologic cancer	0.000417	0.000637	CcSEcCtD
Terlipressin—Hot flush—Doxorubicin—hematologic cancer	0.000416	0.000637	CcSEcCtD
Terlipressin—Menopausal symptoms—Doxorubicin—hematologic cancer	0.000413	0.000631	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Carmustine—hematologic cancer	0.000412	0.00063	CcSEcCtD
Terlipressin—Vomiting—Vinblastine—hematologic cancer	0.000412	0.00063	CcSEcCtD
Terlipressin—Nausea—Nilotinib—hematologic cancer	0.00041	0.000628	CcSEcCtD
Terlipressin—Diarrhoea—Lenalidomide—hematologic cancer	0.00041	0.000627	CcSEcCtD
Terlipressin—Acute coronary syndrome—Prednisone—hematologic cancer	0.000409	0.000625	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Alitretinoin—hematologic cancer	0.000408	0.000624	CcSEcCtD
Terlipressin—Nausea—Imatinib—hematologic cancer	0.000408	0.000624	CcSEcCtD
Terlipressin—Myocardial infarction—Prednisone—hematologic cancer	0.000406	0.000622	CcSEcCtD
Terlipressin—Abdominal pain—Thiotepa—hematologic cancer	0.000406	0.000621	CcSEcCtD
Terlipressin—Headache—Vinblastine—hematologic cancer	0.000405	0.00062	CcSEcCtD
Terlipressin—Diarrhoea—Hydroxyurea—hematologic cancer	0.000404	0.000618	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Ifosfamide—hematologic cancer	0.000403	0.000617	CcSEcCtD
Terlipressin—Nausea—Cladribine—hematologic cancer	0.000401	0.000613	CcSEcCtD
Terlipressin—Cardiac failure—Doxorubicin—hematologic cancer	0.000399	0.00061	CcSEcCtD
Terlipressin—Dyspnoea—Mitoxantrone—hematologic cancer	0.000395	0.000605	CcSEcCtD
Terlipressin—Dyspnoea—Irinotecan—hematologic cancer	0.000395	0.000605	CcSEcCtD
Terlipressin—Nervous system disorder—Cisplatin—hematologic cancer	0.000395	0.000604	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Vincristine—hematologic cancer	0.000393	0.000602	CcSEcCtD
Terlipressin—Tachycardia—Cisplatin—hematologic cancer	0.000393	0.000601	CcSEcCtD
Terlipressin—Abdominal pain—Thalidomide—hematologic cancer	0.000393	0.000601	CcSEcCtD
Terlipressin—Vomiting—Melphalan—hematologic cancer	0.000391	0.000599	CcSEcCtD
Terlipressin—Skin disorder—Cisplatin—hematologic cancer	0.000391	0.000599	CcSEcCtD
Terlipressin—Hyponatraemia—Doxorubicin—hematologic cancer	0.000391	0.000598	CcSEcCtD
Terlipressin—Hypertension—Etoposide—hematologic cancer	0.00039	0.000597	CcSEcCtD
Terlipressin—Angiopathy—Betamethasone—hematologic cancer	0.000388	0.000593	CcSEcCtD
Terlipressin—Angiopathy—Dexamethasone—hematologic cancer	0.000388	0.000593	CcSEcCtD
Terlipressin—Dyspnoea—Gemcitabine—hematologic cancer	0.000385	0.000589	CcSEcCtD
Terlipressin—Hypertension—Prednisolone—hematologic cancer	0.000385	0.000589	CcSEcCtD
Terlipressin—Chest pain—Etoposide—hematologic cancer	0.000385	0.000589	CcSEcCtD
Terlipressin—Nausea—Vinblastine—hematologic cancer	0.000384	0.000588	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Irinotecan—hematologic cancer	0.000383	0.000586	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—hematologic cancer	0.000382	0.000585	CcSEcCtD
Terlipressin—Vomiting—Lenalidomide—hematologic cancer	0.000381	0.000582	CcSEcCtD
Terlipressin—Bradycardia—Prednisone—hematologic cancer	0.000379	0.00058	CcSEcCtD
Terlipressin—Abdominal pain—Carmustine—hematologic cancer	0.000377	0.000577	CcSEcCtD
Terlipressin—Diarrhoea—Bortezomib—hematologic cancer	0.000377	0.000577	CcSEcCtD
Terlipressin—Vomiting—Hydroxyurea—hematologic cancer	0.000375	0.000574	CcSEcCtD
Terlipressin—Headache—Lenalidomide—hematologic cancer	0.000375	0.000574	CcSEcCtD
Terlipressin—Abdominal pain—Alitretinoin—hematologic cancer	0.000374	0.000572	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Gemcitabine—hematologic cancer	0.000373	0.000571	CcSEcCtD
Terlipressin—Headache—Hydroxyurea—hematologic cancer	0.00037	0.000566	CcSEcCtD
Terlipressin—Abdominal pain—Ifosfamide—hematologic cancer	0.000369	0.000565	CcSEcCtD
Terlipressin—Diarrhoea—Vinorelbine—hematologic cancer	0.000368	0.000563	CcSEcCtD
Terlipressin—Nausea—Melphalan—hematologic cancer	0.000366	0.00056	CcSEcCtD
Terlipressin—Tachycardia—Etoposide—hematologic cancer	0.00036	0.000551	CcSEcCtD
Terlipressin—Abdominal pain—Vincristine—hematologic cancer	0.00036	0.000551	CcSEcCtD
Terlipressin—Dyspnoea—Cisplatin—hematologic cancer	0.000359	0.000549	CcSEcCtD
Terlipressin—Skin disorder—Etoposide—hematologic cancer	0.000358	0.000548	CcSEcCtD
Terlipressin—Nausea—Lenalidomide—hematologic cancer	0.000356	0.000544	CcSEcCtD
Terlipressin—Tachycardia—Prednisolone—hematologic cancer	0.000355	0.000543	CcSEcCtD
Terlipressin—Hypertension—Triamcinolone—hematologic cancer	0.000354	0.000542	CcSEcCtD
Terlipressin—Diarrhoea—Thiotepa—hematologic cancer	0.000351	0.000538	CcSEcCtD
Terlipressin—Abdominal pain—Irinotecan—hematologic cancer	0.000351	0.000537	CcSEcCtD
Terlipressin—Abdominal pain—Mitoxantrone—hematologic cancer	0.000351	0.000537	CcSEcCtD
Terlipressin—Nausea—Hydroxyurea—hematologic cancer	0.000351	0.000536	CcSEcCtD
Terlipressin—Vomiting—Bortezomib—hematologic cancer	0.00035	0.000536	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Cisplatin—hematologic cancer	0.000348	0.000532	CcSEcCtD
Terlipressin—Vomiting—Bleomycin—hematologic cancer	0.000348	0.000532	CcSEcCtD
Terlipressin—Headache—Bortezomib—hematologic cancer	0.000345	0.000528	CcSEcCtD
Terlipressin—Vomiting—Vinorelbine—hematologic cancer	0.000342	0.000523	CcSEcCtD
Terlipressin—Diarrhoea—Thalidomide—hematologic cancer	0.00034	0.00052	CcSEcCtD
Terlipressin—Angiopathy—Prednisone—hematologic cancer	0.000338	0.000517	CcSEcCtD
Terlipressin—Headache—Vinorelbine—hematologic cancer	0.000337	0.000516	CcSEcCtD
Terlipressin—Dyspnoea—Etoposide—hematologic cancer	0.000329	0.000503	CcSEcCtD
Terlipressin—Nausea—Bortezomib—hematologic cancer	0.000327	0.000501	CcSEcCtD
Terlipressin—Tachycardia—Triamcinolone—hematologic cancer	0.000327	0.0005	CcSEcCtD
Terlipressin—Vomiting—Thiotepa—hematologic cancer	0.000327	0.0005	CcSEcCtD
Terlipressin—Diarrhoea—Carmustine—hematologic cancer	0.000326	0.0005	CcSEcCtD
Terlipressin—Nausea—Bleomycin—hematologic cancer	0.000325	0.000497	CcSEcCtD
Terlipressin—Malnutrition—Prednisone—hematologic cancer	0.000324	0.000496	CcSEcCtD
Terlipressin—Diarrhoea—Alitretinoin—hematologic cancer	0.000323	0.000495	CcSEcCtD
Terlipressin—Headache—Thiotepa—hematologic cancer	0.000322	0.000492	CcSEcCtD
Terlipressin—Hypertension—Dexamethasone—hematologic cancer	0.000321	0.000492	CcSEcCtD
Terlipressin—Hypertension—Betamethasone—hematologic cancer	0.000321	0.000492	CcSEcCtD
Terlipressin—Diarrhoea—Ifosfamide—hematologic cancer	0.00032	0.000489	CcSEcCtD
Terlipressin—Nausea—Vinorelbine—hematologic cancer	0.000319	0.000489	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000319	0.000487	CcSEcCtD
Terlipressin—Vomiting—Thalidomide—hematologic cancer	0.000316	0.000483	CcSEcCtD
Terlipressin—Diarrhoea—Vincristine—hematologic cancer	0.000312	0.000477	CcSEcCtD
Terlipressin—Headache—Thalidomide—hematologic cancer	0.000311	0.000476	CcSEcCtD
Terlipressin—Nausea—Thiotepa—hematologic cancer	0.000305	0.000467	CcSEcCtD
Terlipressin—Diarrhoea—Mitoxantrone—hematologic cancer	0.000304	0.000464	CcSEcCtD
Terlipressin—Diarrhoea—Irinotecan—hematologic cancer	0.000304	0.000464	CcSEcCtD
Terlipressin—Vomiting—Carmustine—hematologic cancer	0.000303	0.000464	CcSEcCtD
Terlipressin—Vomiting—Alitretinoin—hematologic cancer	0.000301	0.00046	CcSEcCtD
Terlipressin—Headache—Carmustine—hematologic cancer	0.000299	0.000457	CcSEcCtD
Terlipressin—Dyspnoea—Triamcinolone—hematologic cancer	0.000298	0.000457	CcSEcCtD
Terlipressin—Nervous system disorder—Betamethasone—hematologic cancer	0.000298	0.000456	CcSEcCtD
Terlipressin—Nervous system disorder—Dexamethasone—hematologic cancer	0.000298	0.000456	CcSEcCtD
Terlipressin—Vomiting—Ifosfamide—hematologic cancer	0.000297	0.000454	CcSEcCtD
Terlipressin—Tachycardia—Dexamethasone—hematologic cancer	0.000296	0.000453	CcSEcCtD
Terlipressin—Tachycardia—Betamethasone—hematologic cancer	0.000296	0.000453	CcSEcCtD
Terlipressin—Bradycardia—Epirubicin—hematologic cancer	0.000296	0.000453	CcSEcCtD
Terlipressin—Headache—Alitretinoin—hematologic cancer	0.000296	0.000453	CcSEcCtD
Terlipressin—Diarrhoea—Gemcitabine—hematologic cancer	0.000296	0.000452	CcSEcCtD
Terlipressin—Nausea—Thalidomide—hematologic cancer	0.000295	0.000452	CcSEcCtD
Terlipressin—Abdominal pain—Etoposide—hematologic cancer	0.000292	0.000446	CcSEcCtD
Terlipressin—Vomiting—Vincristine—hematologic cancer	0.00029	0.000443	CcSEcCtD
Terlipressin—Cardiac disorder—Methotrexate—hematologic cancer	0.000289	0.000442	CcSEcCtD
Terlipressin—Headache—Vincristine—hematologic cancer	0.000285	0.000437	CcSEcCtD
Terlipressin—Nausea—Carmustine—hematologic cancer	0.000283	0.000434	CcSEcCtD
Terlipressin—Angiopathy—Methotrexate—hematologic cancer	0.000282	0.000432	CcSEcCtD
Terlipressin—Vomiting—Irinotecan—hematologic cancer	0.000282	0.000432	CcSEcCtD
Terlipressin—Vomiting—Mitoxantrone—hematologic cancer	0.000282	0.000432	CcSEcCtD
Terlipressin—Nausea—Alitretinoin—hematologic cancer	0.000281	0.00043	CcSEcCtD
Terlipressin—Hypertension—Prednisone—hematologic cancer	0.00028	0.000428	CcSEcCtD
Terlipressin—Headache—Mitoxantrone—hematologic cancer	0.000278	0.000425	CcSEcCtD
Terlipressin—Headache—Irinotecan—hematologic cancer	0.000278	0.000425	CcSEcCtD
Terlipressin—Nausea—Ifosfamide—hematologic cancer	0.000278	0.000425	CcSEcCtD
Terlipressin—Diarrhoea—Cisplatin—hematologic cancer	0.000276	0.000422	CcSEcCtD
Terlipressin—Vomiting—Gemcitabine—hematologic cancer	0.000275	0.00042	CcSEcCtD
Terlipressin—Bradycardia—Doxorubicin—hematologic cancer	0.000274	0.00042	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	0.000274	0.000419	CcSEcCtD
Terlipressin—Malnutrition—Methotrexate—hematologic cancer	0.000271	0.000414	CcSEcCtD
Terlipressin—Headache—Gemcitabine—hematologic cancer	0.000271	0.000414	CcSEcCtD
Terlipressin—Nausea—Vincristine—hematologic cancer	0.000271	0.000414	CcSEcCtD
Terlipressin—Cardiac disorder—Epirubicin—hematologic cancer	0.00027	0.000413	CcSEcCtD
Terlipressin—Angiopathy—Epirubicin—hematologic cancer	0.000264	0.000404	CcSEcCtD
Terlipressin—Nausea—Mitoxantrone—hematologic cancer	0.000263	0.000403	CcSEcCtD
Terlipressin—Nausea—Irinotecan—hematologic cancer	0.000263	0.000403	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000262	0.000401	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000262	0.000401	CcSEcCtD
Terlipressin—Nervous system disorder—Prednisone—hematologic cancer	0.000259	0.000397	CcSEcCtD
Terlipressin—Tachycardia—Prednisone—hematologic cancer	0.000258	0.000395	CcSEcCtD
Terlipressin—Skin disorder—Prednisone—hematologic cancer	0.000257	0.000393	CcSEcCtD
Terlipressin—Nausea—Gemcitabine—hematologic cancer	0.000257	0.000393	CcSEcCtD
Terlipressin—Vomiting—Cisplatin—hematologic cancer	0.000256	0.000392	CcSEcCtD
Terlipressin—Malnutrition—Epirubicin—hematologic cancer	0.000253	0.000388	CcSEcCtD
Terlipressin—Diarrhoea—Etoposide—hematologic cancer	0.000252	0.000386	CcSEcCtD
Terlipressin—Cardiac disorder—Doxorubicin—hematologic cancer	0.00025	0.000383	CcSEcCtD
Terlipressin—Angiopathy—Doxorubicin—hematologic cancer	0.000244	0.000374	CcSEcCtD
Terlipressin—Abdominal pain—Betamethasone—hematologic cancer	0.00024	0.000367	CcSEcCtD
Terlipressin—Abdominal pain—Dexamethasone—hematologic cancer	0.00024	0.000367	CcSEcCtD
Terlipressin—Nausea—Cisplatin—hematologic cancer	0.000239	0.000366	CcSEcCtD
Terlipressin—Vomiting—Etoposide—hematologic cancer	0.000235	0.000359	CcSEcCtD
Terlipressin—Malnutrition—Doxorubicin—hematologic cancer	0.000234	0.000359	CcSEcCtD
Terlipressin—Headache—Etoposide—hematologic cancer	0.000231	0.000354	CcSEcCtD
Terlipressin—Chest pain—Methotrexate—hematologic cancer	0.000231	0.000353	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	0.000229	0.00035	CcSEcCtD
Terlipressin—Headache—Prednisolone—hematologic cancer	0.000228	0.000349	CcSEcCtD
Terlipressin—Nausea—Etoposide—hematologic cancer	0.000219	0.000335	CcSEcCtD
Terlipressin—Hypertension—Epirubicin—hematologic cancer	0.000219	0.000335	CcSEcCtD
Terlipressin—Nervous system disorder—Methotrexate—hematologic cancer	0.000217	0.000332	CcSEcCtD
Terlipressin—Nausea—Prednisolone—hematologic cancer	0.000216	0.000331	CcSEcCtD
Terlipressin—Chest pain—Epirubicin—hematologic cancer	0.000216	0.00033	CcSEcCtD
Terlipressin—Skin disorder—Methotrexate—hematologic cancer	0.000215	0.000328	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	0.000214	0.000328	CcSEcCtD
Terlipressin—Vomiting—Triamcinolone—hematologic cancer	0.000213	0.000326	CcSEcCtD
Terlipressin—Headache—Triamcinolone—hematologic cancer	0.00021	0.000321	CcSEcCtD
Terlipressin—Abdominal pain—Prednisone—hematologic cancer	0.000209	0.00032	CcSEcCtD
Terlipressin—Diarrhoea—Betamethasone—hematologic cancer	0.000208	0.000318	CcSEcCtD
Terlipressin—Diarrhoea—Dexamethasone—hematologic cancer	0.000208	0.000318	CcSEcCtD
Terlipressin—Nervous system disorder—Epirubicin—hematologic cancer	0.000203	0.00031	CcSEcCtD
Terlipressin—Hypertension—Doxorubicin—hematologic cancer	0.000202	0.00031	CcSEcCtD
Terlipressin—Tachycardia—Epirubicin—hematologic cancer	0.000202	0.000309	CcSEcCtD
Terlipressin—Skin disorder—Epirubicin—hematologic cancer	0.000201	0.000307	CcSEcCtD
Terlipressin—Chest pain—Doxorubicin—hematologic cancer	0.0002	0.000305	CcSEcCtD
Terlipressin—Nausea—Triamcinolone—hematologic cancer	0.000199	0.000304	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	0.000198	0.000303	CcSEcCtD
Terlipressin—Dyspnoea—Methotrexate—hematologic cancer	0.000197	0.000301	CcSEcCtD
Terlipressin—Vomiting—Dexamethasone—hematologic cancer	0.000193	0.000295	CcSEcCtD
Terlipressin—Vomiting—Betamethasone—hematologic cancer	0.000193	0.000295	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Methotrexate—hematologic cancer	0.000191	0.000292	CcSEcCtD
Terlipressin—Headache—Dexamethasone—hematologic cancer	0.00019	0.000291	CcSEcCtD
Terlipressin—Headache—Betamethasone—hematologic cancer	0.00019	0.000291	CcSEcCtD
Terlipressin—Nervous system disorder—Doxorubicin—hematologic cancer	0.000188	0.000287	CcSEcCtD
Terlipressin—Tachycardia—Doxorubicin—hematologic cancer	0.000187	0.000286	CcSEcCtD
Terlipressin—Skin disorder—Doxorubicin—hematologic cancer	0.000186	0.000284	CcSEcCtD
Terlipressin—Dyspnoea—Epirubicin—hematologic cancer	0.000184	0.000282	CcSEcCtD
Terlipressin—Diarrhoea—Prednisone—hematologic cancer	0.000181	0.000277	CcSEcCtD
Terlipressin—Nausea—Betamethasone—hematologic cancer	0.00018	0.000276	CcSEcCtD
Terlipressin—Nausea—Dexamethasone—hematologic cancer	0.00018	0.000276	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Epirubicin—hematologic cancer	0.000179	0.000273	CcSEcCtD
Terlipressin—Abdominal pain—Methotrexate—hematologic cancer	0.000175	0.000267	CcSEcCtD
Terlipressin—Dyspnoea—Doxorubicin—hematologic cancer	0.000171	0.000261	CcSEcCtD
Terlipressin—Vomiting—Prednisone—hematologic cancer	0.000168	0.000257	CcSEcCtD
Terlipressin—Headache—Prednisone—hematologic cancer	0.000166	0.000253	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	0.000165	0.000253	CcSEcCtD
Terlipressin—Abdominal pain—Epirubicin—hematologic cancer	0.000164	0.00025	CcSEcCtD
Terlipressin—Nausea—Prednisone—hematologic cancer	0.000157	0.00024	CcSEcCtD
Terlipressin—Abdominal pain—Doxorubicin—hematologic cancer	0.000151	0.000231	CcSEcCtD
Terlipressin—Diarrhoea—Methotrexate—hematologic cancer	0.000151	0.000231	CcSEcCtD
Terlipressin—Diarrhoea—Epirubicin—hematologic cancer	0.000142	0.000217	CcSEcCtD
Terlipressin—Vomiting—Methotrexate—hematologic cancer	0.000141	0.000215	CcSEcCtD
Terlipressin—Headache—Methotrexate—hematologic cancer	0.000138	0.000212	CcSEcCtD
Terlipressin—Vomiting—Epirubicin—hematologic cancer	0.000132	0.000201	CcSEcCtD
Terlipressin—Nausea—Methotrexate—hematologic cancer	0.000131	0.000201	CcSEcCtD
Terlipressin—Diarrhoea—Doxorubicin—hematologic cancer	0.000131	0.0002	CcSEcCtD
Terlipressin—Headache—Epirubicin—hematologic cancer	0.00013	0.000198	CcSEcCtD
Terlipressin—Octreotide—MPO—hematologic cancer	0.000124	1	CrCbGaD
Terlipressin—AVPR1A—Signaling Pathways—IL3—hematologic cancer	0.000124	0.000359	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TERT—hematologic cancer	0.000124	0.000359	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL3—hematologic cancer	0.000123	0.000356	CbGpPWpGaD
Terlipressin—Nausea—Epirubicin—hematologic cancer	0.000123	0.000188	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CG—hematologic cancer	0.000123	0.000355	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTPN1—hematologic cancer	0.000122	0.000353	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CG—hematologic cancer	0.000122	0.000352	CbGpPWpGaD
Terlipressin—Vomiting—Doxorubicin—hematologic cancer	0.000122	0.000186	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—PTPN1—hematologic cancer	0.000121	0.00035	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PDGFB—hematologic cancer	0.000121	0.00035	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PTPN11—hematologic cancer	0.000121	0.000348	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—RASGRP1—hematologic cancer	0.00012	0.000347	CbGpPWpGaD
Terlipressin—Headache—Doxorubicin—hematologic cancer	0.00012	0.000183	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—HSP90AA1—hematologic cancer	0.00012	0.000346	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SYK—hematologic cancer	0.00012	0.000346	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PTPN11—hematologic cancer	0.00012	0.000346	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—RASGRP1—hematologic cancer	0.000119	0.000345	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HSP90AA1—hematologic cancer	0.000119	0.000344	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SYK—hematologic cancer	0.000119	0.000344	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CD—hematologic cancer	0.000119	0.000343	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TSC2—hematologic cancer	0.000119	0.000342	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CD—hematologic cancer	0.000118	0.000341	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CREB1—hematologic cancer	0.000117	0.000338	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CREB1—hematologic cancer	0.000116	0.000335	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—STAT1—hematologic cancer	0.000116	0.000334	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—STAT1—hematologic cancer	0.000115	0.000331	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CCL2—hematologic cancer	0.000114	0.00033	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL6R—hematologic cancer	0.000114	0.000329	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—FGFR3—hematologic cancer	0.000114	0.000329	CbGpPWpGaD
Terlipressin—Nausea—Doxorubicin—hematologic cancer	0.000114	0.000174	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—CCL2—hematologic cancer	0.000114	0.000328	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL6R—hematologic cancer	0.000113	0.000327	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MAPK14—hematologic cancer	0.000113	0.000326	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3R1—hematologic cancer	0.000112	0.000324	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3R1—hematologic cancer	0.000111	0.000322	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ESR1—hematologic cancer	0.000111	0.00032	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—FN1—hematologic cancer	0.000109	0.000316	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—JAK2—hematologic cancer	0.000109	0.000315	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—MAP2K1—hematologic cancer	0.000109	0.000314	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—JAK2—hematologic cancer	0.000108	0.000313	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GRB2—hematologic cancer	0.000108	0.000312	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—BAD—hematologic cancer	0.000108	0.000312	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NFKBIA—hematologic cancer	0.000108	0.000312	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CD—hematologic cancer	0.000108	0.000312	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—MAP2K1—hematologic cancer	0.000108	0.000312	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PDGFA—hematologic cancer	0.000108	0.000312	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GRB2—hematologic cancer	0.000107	0.00031	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CD—hematologic cancer	0.000107	0.00031	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PDGFA—hematologic cancer	0.000107	0.000309	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NOTCH1—hematologic cancer	0.000107	0.000309	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KITLG—hematologic cancer	0.000106	0.000307	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KITLG—hematologic cancer	0.000106	0.000305	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CD80—hematologic cancer	0.000105	0.000303	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CG—hematologic cancer	0.000105	0.000302	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KIT—hematologic cancer	0.000105	0.000302	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—NRAS—hematologic cancer	0.000105	0.000302	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—STAT5A—hematologic cancer	0.000104	0.0003	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000104	0.000299	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—STAT5A—hematologic cancer	0.000103	0.000298	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CDKN2B—hematologic cancer	0.000103	0.000298	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000103	0.000297	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PTPN11—hematologic cancer	0.000103	0.000297	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CDKN2B—hematologic cancer	0.000102	0.000295	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3R1—hematologic cancer	0.000102	0.000294	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3R1—hematologic cancer	0.000101	0.000292	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—MAPK3—hematologic cancer	0.0001	0.00029	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CD86—hematologic cancer	9.97e-05	0.000288	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CREB1—hematologic cancer	9.97e-05	0.000288	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—JAK2—hematologic cancer	9.91e-05	0.000286	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CD86—hematologic cancer	9.89e-05	0.000286	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—BRAF—hematologic cancer	9.84e-05	0.000284	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—JAK2—hematologic cancer	9.84e-05	0.000284	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HES1—hematologic cancer	9.83e-05	0.000284	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NCOR1—hematologic cancer	9.77e-05	0.000282	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HES1—hematologic cancer	9.76e-05	0.000282	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCL2—hematologic cancer	9.75e-05	0.000282	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL6R—hematologic cancer	9.72e-05	0.000281	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CREBBP—hematologic cancer	9.71e-05	0.00028	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NCOR1—hematologic cancer	9.7e-05	0.00028	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CSF2—hematologic cancer	9.66e-05	0.000279	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FGF1—hematologic cancer	9.66e-05	0.000279	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CSF2—hematologic cancer	9.59e-05	0.000277	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FGF1—hematologic cancer	9.59e-05	0.000277	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FOXO1—hematologic cancer	9.52e-05	0.000275	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—IL2—hematologic cancer	9.52e-05	0.000275	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PDGFRB—hematologic cancer	9.51e-05	0.000275	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FOXO1—hematologic cancer	9.46e-05	0.000273	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—IL2—hematologic cancer	9.45e-05	0.000273	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PDGFRB—hematologic cancer	9.44e-05	0.000273	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CB—hematologic cancer	9.41e-05	0.000272	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PDGFRA—hematologic cancer	9.36e-05	0.00027	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CB—hematologic cancer	9.34e-05	0.00027	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—JAK1—hematologic cancer	9.33e-05	0.000269	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PRKCG—hematologic cancer	9.33e-05	0.000269	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PDGFRA—hematologic cancer	9.29e-05	0.000268	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MAP2K1—hematologic cancer	9.26e-05	0.000268	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—JAK1—hematologic cancer	9.26e-05	0.000267	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PRKCG—hematologic cancer	9.26e-05	0.000267	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CD—hematologic cancer	9.2e-05	0.000266	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CA—hematologic cancer	9.12e-05	0.000263	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—KRAS—hematologic cancer	9.01e-05	0.00026	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—FGF2—hematologic cancer	8.81e-05	0.000254	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL2RA—hematologic cancer	8.71e-05	0.000252	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3R1—hematologic cancer	8.69e-05	0.000251	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL2RA—hematologic cancer	8.65e-05	0.00025	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL2—hematologic cancer	8.64e-05	0.00025	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TERT—hematologic cancer	8.61e-05	0.000249	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL2—hematologic cancer	8.58e-05	0.000248	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TERT—hematologic cancer	8.55e-05	0.000247	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—JAK2—hematologic cancer	8.45e-05	0.000244	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PDGFB—hematologic cancer	8.41e-05	0.000243	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PDGFB—hematologic cancer	8.35e-05	0.000241	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CA—hematologic cancer	8.28e-05	0.000239	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MDM2—hematologic cancer	8.24e-05	0.000238	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TSC2—hematologic cancer	8.22e-05	0.000237	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TSC2—hematologic cancer	8.16e-05	0.000236	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MTOR—hematologic cancer	8.02e-05	0.000232	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CB—hematologic cancer	8.02e-05	0.000232	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FGFR3—hematologic cancer	7.9e-05	0.000228	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FGFR3—hematologic cancer	7.85e-05	0.000227	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAPK14—hematologic cancer	7.83e-05	0.000226	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAPK14—hematologic cancer	7.77e-05	0.000224	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ESR1—hematologic cancer	7.68e-05	0.000222	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—HRAS—hematologic cancer	7.66e-05	0.000221	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ESR1—hematologic cancer	7.62e-05	0.00022	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FN1—hematologic cancer	7.58e-05	0.000219	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CDKN1B—hematologic cancer	7.53e-05	0.000217	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FN1—hematologic cancer	7.53e-05	0.000217	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NFKBIA—hematologic cancer	7.49e-05	0.000216	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—BAD—hematologic cancer	7.49e-05	0.000216	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—AKT1—hematologic cancer	7.45e-05	0.000215	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—BAD—hematologic cancer	7.44e-05	0.000215	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NFKBIA—hematologic cancer	7.44e-05	0.000215	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NOTCH1—hematologic cancer	7.42e-05	0.000214	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CASP3—hematologic cancer	7.38e-05	0.000213	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL2—hematologic cancer	7.37e-05	0.000213	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NOTCH1—hematologic cancer	7.37e-05	0.000213	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL6—hematologic cancer	7.33e-05	0.000212	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CD80—hematologic cancer	7.27e-05	0.00021	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CG—hematologic cancer	7.26e-05	0.00021	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KIT—hematologic cancer	7.26e-05	0.00021	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—NRAS—hematologic cancer	7.26e-05	0.00021	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CD80—hematologic cancer	7.22e-05	0.000208	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CG—hematologic cancer	7.2e-05	0.000208	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KIT—hematologic cancer	7.2e-05	0.000208	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—NRAS—hematologic cancer	7.2e-05	0.000208	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCND1—hematologic cancer	7.18e-05	0.000207	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—JUN—hematologic cancer	7.17e-05	0.000207	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTPN11—hematologic cancer	7.13e-05	0.000206	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTPN11—hematologic cancer	7.08e-05	0.000204	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—MAPK3—hematologic cancer	6.95e-05	0.000201	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CDKN1A—hematologic cancer	6.95e-05	0.000201	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PTEN—hematologic cancer	6.93e-05	0.0002	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CREB1—hematologic cancer	6.91e-05	0.000199	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—MAPK3—hematologic cancer	6.9e-05	0.000199	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CREB1—hematologic cancer	6.86e-05	0.000198	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—BRAF—hematologic cancer	6.82e-05	0.000197	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MAPK8—hematologic cancer	6.78e-05	0.000196	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—BRAF—hematologic cancer	6.77e-05	0.000196	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—AKT1—hematologic cancer	6.76e-05	0.000195	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCL2—hematologic cancer	6.76e-05	0.000195	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL6R—hematologic cancer	6.74e-05	0.000195	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CREBBP—hematologic cancer	6.73e-05	0.000194	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCL2—hematologic cancer	6.71e-05	0.000194	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL6R—hematologic cancer	6.69e-05	0.000193	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CREBBP—hematologic cancer	6.68e-05	0.000193	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EP300—hematologic cancer	6.61e-05	0.000191	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SRC—hematologic cancer	6.43e-05	0.000186	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAP2K1—hematologic cancer	6.42e-05	0.000185	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CD—hematologic cancer	6.38e-05	0.000184	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAP2K1—hematologic cancer	6.38e-05	0.000184	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CD—hematologic cancer	6.33e-05	0.000183	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CA—hematologic cancer	6.32e-05	0.000182	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CA—hematologic cancer	6.27e-05	0.000181	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—VEGFA—hematologic cancer	6.26e-05	0.000181	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—KRAS—hematologic cancer	6.25e-05	0.00018	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—KRAS—hematologic cancer	6.2e-05	0.000179	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—STAT3—hematologic cancer	6.2e-05	0.000179	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NRAS—hematologic cancer	6.18e-05	0.000179	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FGF2—hematologic cancer	6.11e-05	0.000176	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FGF2—hematologic cancer	6.06e-05	0.000175	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3R1—hematologic cancer	6.02e-05	0.000174	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3R1—hematologic cancer	5.98e-05	0.000173	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MAPK3—hematologic cancer	5.92e-05	0.000171	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—JAK2—hematologic cancer	5.85e-05	0.000169	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—JAK2—hematologic cancer	5.81e-05	0.000168	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MYC—hematologic cancer	5.76e-05	0.000166	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TGFB1—hematologic cancer	5.75e-05	0.000166	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CA—hematologic cancer	5.74e-05	0.000166	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MDM2—hematologic cancer	5.71e-05	0.000165	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CA—hematologic cancer	5.7e-05	0.000165	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MDM2—hematologic cancer	5.67e-05	0.000164	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MTOR—hematologic cancer	5.56e-05	0.000161	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CB—hematologic cancer	5.56e-05	0.000161	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MTOR—hematologic cancer	5.52e-05	0.000159	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CB—hematologic cancer	5.52e-05	0.000159	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KRAS—hematologic cancer	5.32e-05	0.000154	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—HRAS—hematologic cancer	5.31e-05	0.000153	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—HRAS—hematologic cancer	5.27e-05	0.000152	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CDKN1B—hematologic cancer	5.22e-05	0.000151	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CDKN1B—hematologic cancer	5.18e-05	0.00015	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—AKT1—hematologic cancer	5.16e-05	0.000149	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—AKT1—hematologic cancer	5.12e-05	0.000148	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CASP3—hematologic cancer	5.11e-05	0.000148	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL2—hematologic cancer	5.11e-05	0.000147	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL6—hematologic cancer	5.08e-05	0.000147	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CASP3—hematologic cancer	5.08e-05	0.000147	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL2—hematologic cancer	5.07e-05	0.000146	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL6—hematologic cancer	5.04e-05	0.000146	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCND1—hematologic cancer	4.98e-05	0.000144	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—JUN—hematologic cancer	4.97e-05	0.000143	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCND1—hematologic cancer	4.94e-05	0.000143	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—JUN—hematologic cancer	4.93e-05	0.000142	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CA—hematologic cancer	4.89e-05	0.000141	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CDKN1A—hematologic cancer	4.82e-05	0.000139	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTEN—hematologic cancer	4.8e-05	0.000139	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CDKN1A—hematologic cancer	4.78e-05	0.000138	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTEN—hematologic cancer	4.77e-05	0.000138	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TP53—hematologic cancer	4.73e-05	0.000137	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAPK8—hematologic cancer	4.7e-05	0.000136	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—AKT1—hematologic cancer	4.69e-05	0.000135	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAPK8—hematologic cancer	4.67e-05	0.000135	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—AKT1—hematologic cancer	4.65e-05	0.000134	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EP300—hematologic cancer	4.58e-05	0.000132	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EP300—hematologic cancer	4.55e-05	0.000131	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HRAS—hematologic cancer	4.52e-05	0.000131	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SRC—hematologic cancer	4.46e-05	0.000129	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SRC—hematologic cancer	4.42e-05	0.000128	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—VEGFA—hematologic cancer	4.34e-05	0.000125	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL6—hematologic cancer	4.33e-05	0.000125	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—VEGFA—hematologic cancer	4.31e-05	0.000124	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—STAT3—hematologic cancer	4.3e-05	0.000124	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NRAS—hematologic cancer	4.29e-05	0.000124	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—STAT3—hematologic cancer	4.27e-05	0.000123	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NRAS—hematologic cancer	4.26e-05	0.000123	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAPK3—hematologic cancer	4.11e-05	0.000119	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAPK3—hematologic cancer	4.08e-05	0.000118	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—AKT1—hematologic cancer	3.99e-05	0.000115	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MYC—hematologic cancer	3.99e-05	0.000115	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TGFB1—hematologic cancer	3.98e-05	0.000115	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MYC—hematologic cancer	3.96e-05	0.000114	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TGFB1—hematologic cancer	3.95e-05	0.000114	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KRAS—hematologic cancer	3.69e-05	0.000107	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KRAS—hematologic cancer	3.66e-05	0.000106	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CA—hematologic cancer	3.39e-05	9.79e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CA—hematologic cancer	3.37e-05	9.72e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TP53—hematologic cancer	3.28e-05	9.47e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TP53—hematologic cancer	3.26e-05	9.4e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HRAS—hematologic cancer	3.14e-05	9.06e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HRAS—hematologic cancer	3.11e-05	8.99e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL6—hematologic cancer	3e-05	8.67e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL6—hematologic cancer	2.98e-05	8.61e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AKT1—hematologic cancer	2.77e-05	8e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AKT1—hematologic cancer	2.75e-05	7.94e-05	CbGpPWpGaD
